12200sek
1,8 %
Date:2026-07-02Time:18:00:00Latest report:Q1-2026List:Mid CapTicker:BIOG B
Market Cap:12 342 msekEnterprise Value:11 470 msekNet Sales:1 544 msekEarnings:332,0 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:122,00
MA50:123,41
MA200:111,41
Price/MA200:9,5 %
RSI (14):52,5
Price/MA50:-1,1 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.